| Fungal Infection |
1 |
1 |
| Antifungal |
0 |
0.67 |
| Hospital |
0 |
0.45 |
| Academia |
0 |
0.36 |
| Hospital-Acquired Infection |
0 |
0.36 |
| Pandemic |
0 |
0.99 |
| Revenue and Practice Management |
0 |
0.25 |
| COVID-19 |
0 |
0.23 |
| Biologic Therapy |
0 |
0.22 |
| Agriculture |
0 |
0.18 |
| Outbreak |
0 |
0.18 |
| Coccidioidomycosis |
0 |
0.15 |
| Candida |
0 |
0.13 |
| Face |
0 |
0.13 |
| Immunocompromise |
0 |
0.13 |
| HIV Infection |
0 |
0.12 |
| Microbiome |
0 |
0.11 |
| Aspergillosis |
0 |
0.09 |
| Cancer |
0 |
0.09 |
| Epidemiology |
0 |
0.09 |
| Spain |
0 |
0.09 |
| Social Determinants of Health |
0 |
0.08 |
| Tuberculosis |
0 |
0.08 |
| Mechanical Ventilation |
0 |
0.06 |
| Parenteral Nutrition |
0 |
0.06 |
| Vaccines |
0 |
0.06 |